VORNADO REALTY TRUST (VNO)       23.5  +1.18 (+5.29%)

23.5  +1.18 (+5.29%)

US9290421091 - REIT - After market: 23.49 -0.01 (-0.04%)


Fundamental Rating

4

Overall VNO gets a fundamental rating of 4 out of 10. We evaluated VNO against 218 industry peers in the Equity Real Estate Investment Trusts (REITs) industry. Both the profitability and the financial health of VNO get a neutral evaluation. Nothing too spectacular is happening here. VNO is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

The Piotroski-F score of VNO is 8.00. This is a very strong score and indicates great health and profitability for VNO.
VNO has a Return On Assets of 0.71%. This is below the industry average of 4.00%. 89% of the industry peers outperform VNO.

VNO has a Return On Equity of 1.90%. This is below the industry average of 9.25%. 87% of the industry peers outperform VNO.
VNO's Profit Margin of 5.52% is worse than the rest of the industry. The industry average Profit Margin is 32.35%. 90% of the industry peers have a better Profit Margin.
VS Industry

ROA (0.71%) VS Industry: 11% outperformed.

0.02
28.72

ROE (1.9%) VS Industry: 13% outperformed.

0.04
125.88

Profit Margin (5.52%) VS Industry: 10% outperformed.

0.16
684.56

Valuation

Valuation Rating

3

With a price book ratio of 0.70, VNO is valued rather cheaply.
Compared to an average industry price book ratio of 1.26, VNO is valued rather cheaply. On top of this, VNO is cheaper than 82% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 17.41, VNO is valued rather cheaply

The Price/Earnings Ratio is 39.17, which means the current valuation is very expensive for VNO.
VNO's Price/Earning Ratio is slightly more expensive than the industry average, which is at 25.04.
The Forward Price/Earnings Ratio of 77.56 indicates a quite expensive current valuation of VNO.
VS Industry

Price/Earnings (39.17) VS Industry: 30% outperformed.

320.00
0.83

Price/Book (0.7) VS Industry: 82% outperformed.

97.19
0.07

Enterprise Value/ EBITDA (13.8) VS Industry: 74% outperformed.

146.17
2.93

Growth

Growth Rating

4

The Earnings Per Share has grown by an impressive 230.43% over the past year.
VNO shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.49%.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The EPS growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

VNO shows a decrease in Revenue. Measured over the last 5 years, the Revenue has been decreasing by -4.53% yearly.
The Revenue is expected to grow by 6.75% on average over the next 5 years.
Measured over the past 5 years, VNO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.34% on average per year.
VNO is expected to show a very negative growth in Earnings Per Share. In the coming 5 years, the EPS will decrease by -28.01% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-33.34% -24.98% 230.43% -38.87% -27.09% -28.01% N/A
Revenue-4.53% -9.77% 43.49% 14.33% 8.28% 7.17% 6.75%

Health

Health Rating

4

VNO is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 0.76.
The Quick Ratio of VNO is much better than the industry average of 0.76.
The Piotroski-F score of VNO is 8.00. This is a very strong score and indicates great health and profitability for VNO.
VNO has a Current Ratio of 1.41. This is a normal value and indicates that VNO is financially healthy and should not expect problems in meeting its short term obligations.

A Quick Ratio of 1.34 indicates that VNO should not have too much problems paying its short term obligations.
Compared to an average industry Debt to Equity Ratio of 1.02, VNO is more dependent on financing than its industry peers.
Based on the Altman-Z score of 0.21, we must say that VNO is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 0.80, VNO is in worse financial state than most of its industry peers. 85% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (1.3) VS Industry: 33% outperformed.

69.38
0.00

Quick Ratio (1.34) VS Industry: 67% outperformed.

0.00
22.38

Current Ratio (1.41) VS Industry: 67% outperformed.

0.00
22.38

Altman-Z (0.21) VS Industry: 15% outperformed.

-1.25
14.35

Dividend

Dividend Rating

6

VNO has a Yearly Dividend Yield of 6.74%, which is a nice return.
VNO's Dividend Yield is a higher than the industry average which is at 4.85.
Compared to an average S&P500 Dividend Yield of 2.41, VNO pays a better dividend.
VNO has been paying a dividend for at least 10 years, so it has a reliable track record.

The dividend of VNO decreases each year by -5.60%.
VNO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
383.67% of the earnings are spent on dividend by VNO. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (6.74%) VS Industry: 76% outperformed.

0.27
22.70

VORNADO REALTY TRUST23.5

NYSE:VNO (1/27/2023, 7:04:00 PM)+1.18 (+5.29%)

After market: 23.49 -0.01 (-0.04%)

Chartmill FA Rating
GICS Sector Real Estate
GICS IndustryGroup Real Estate
GICS Industry Equity Real Estate Investment Trusts (REITs)
Earnings (Last) 10-31 2022-10-31/amc Earnings (Next) 02-13 2023-02-13
Inst Owners 86.51% Inst Owner Change 0.9%
Ins Owners 0.83% Ins Owner Change 0%
Market Cap 4.51B Analysts 49
Price Target 23.46 (-0.17%)

Dividend
Dividend Yield 6.74% Dividend Growth -5.6%
DP 383.67% Ex-Date 01-27 2023-01-27 (0.375)

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 46.59%
Min EPS beat(2) 14.01% Max EPS beat(2) 79.16%
EPS beat(4) 3 Avg EPS beat(4) 29.26%
Min EPS beat(4) -74.17% Max EPS beat(4) 98.02%
Revenue beat(2) 2 Avg Revenue beat(2) 51.11%
Min Revenue beat(2) 0.27% Max Revenue beat(2) 101.96%
Revenue beat(4) 3 Avg Revenue beat(4) 26.13%
Min Revenue beat(4) -0.02% Max Revenue beat(4) 101.96%
PT rev (1m) -1.94% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 39.17
Fwd PE 77.56
P/S 2.03
P/FCF N/A
P/OCF 5.34
P/B 0.7
P/tB 0.72
EV/EBITDA 13.8
EPS(TTM) 0.6 EY 2.55%
EPS(NY) 0.3 Fwd EY 1.29%
FCF(TTM) -0.07 FCFY N/A
OCF(TTM) 4.4 OCFY 18.71%
SpS 11.55 BVpS 33.56
TBVpS 32.82 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 0.71%
ROE 1.9%
ROIC 1.75%
ROICexc 1.85%
ROICexgc 1.95%
OM 15.98%
PM 5.52%
GM 51.28%
ROICexgc(3y) 1.46% ROICexcg growth 3Y -24.45%
ROICexcg growth 5Y -12.1% ROICexc(3y) 1.41%
ROICexc growth 3Y -24.73% ROICexc growth 5Y -12.27%
OM growth 3Y -19.52% OM growth 5Y -12.84%
PM growth 3Y -29.02% PM growth 5Y -31.15%
GM growth 3Y -3.51% GM growth 5Y -2.94%
F-Score 8 Asset Turnover 0.13

Health
Industry RankSector Rank
Debt/Equity 1.3
Debt/FCF N/A
Debt/EBITDA 9.6
Cap/Depr 165.03%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.34
Altman-Z 0.21
F-Score 8 WACC 6.11%
ROIC/WACC 0.32 Cap/Depr(3y) 199.3%
Cap/Depr(5y) 196.34% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 230.43% EPS 3Y -24.98%
EPS 5Y -33.34% EPS growth Q2Q -5%
EPS Next Y -38.87% EPS Next 2Y -27.09%
EPS Next 3Y -28.01% EPS Next 5Y N/A
Revenue growth 1Y 43.49% Revenue growth 3Y -9.77%
Revenue growth 5Y -4.53% Revenue growth Q2Q 11.78%
Revenue Next Year 14.33% Revenue Next 2Y 8.28%
Revenue Next 3Y 7.17% Revenue Next 5Y 6.75%
EBIT growth 1Y 84.57% EBIT growth 3Y -27.39%
EBIT growth 5Y -16.78% EBIT Next Year 153.61%
EBIT Next 3Y 38.78% EBIT Next 5Y 24.77%
FCF growth 1Y 96.68% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y 85.03%
OCF growth 3Y -1.72% OCF growth 5Y -5.2%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA